Crossmark

Noncanonical hedgehog pathway activation through SRF–MKL1 promotes drug resistance in basal cell carcinomas

Crossref DOI link: https://doi.org/10.1038/nm.4476

Published Online: 2018-02-05

Published Print: 2018-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Whitson, Ramon J

Lee, Alex

Urman, Nicole M

Mirza, Amar

Yao, Catherine Y

Brown, Alexander S

Li, Jiang R

Shankar, Gautam

Fry, Micah A

Atwood, Scott X http://orcid.org/0000-0001-7407-9792
Lee, Eunice Y

Hollmig, S Tyler

Aasi, Sumaira Z

Sarin, Kavita Y http://orcid.org/0000-0001-5363-3053
Scott, Matthew P

Epstein, Ervin H Jr

Tang, Jean Y

Oro, Anthony E http://orcid.org/0000-0002-6261-138X
License Information

Text and Data Mining valid from 2018-02-05
More Information

Article History

Received: 16 December 2016

Accepted: 19 December 2017

First Online: 5 February 2018

Competing interests

: A.E.O. is a clinical investigator funded by Novartis.